Day 3 of the SDPA Annual Summer Conference kicked off with Dr. Neal Bhatia presenting on actinic keratoses (AK). He began his lecture by encouraging providers to examine our definition of actinic keratoses to ourselves and patients. Actinic keratoses can be viewed as a symptom of a bigger problem with at least 8% of AKs …
Ingenol mebutate (IngMeb) and diclofenac sodium (DS) are both approved for treating actinic keratosis (AK) on the face and scalp. A recent study compared them head-to-head for efficacy and safety. The authors hypothesized that due to factors such as superior clinical outcomes, favorable tolerability, and shorter treatment duration, IngMeb may be preferred by patients and …